FANCB: Fanconi Anemia Complementation Group B
A key component of the FA core complex involved in DNA interstrand crosslink repair and bone marrow failure syndrome
Gene Information Card
| Symbol | FANCB |
|---|---|
| Full Name | FA complementation group B |
| Gene Type | protein-coding |
| Chromosomal Location | Xp22.2 |
| NCBI Gene ID | 2187 ncbi.nlm.nih.gov/gene/2187 |
| Ensembl ID | ENSG00000181544 |
| UniProt ID | Q8NB91 |
| OMIM ID | 300515 |
| HGNC ID | 3583 |
| Aliases | FAAP95, FA-B, FAB, FANCB1 |
Description
FANCB encodes a protein that is a component of the Fanconi anemia (FA) core complex, which is essential for the repair of DNA interstrand crosslinks (ICLs). The FA core complex monoubiquitinates FANCD2 and FANCI, targeting them to chromatin to facilitate downstream repair. FANCB is required for the stability and nuclear localization of the core complex. Mutations in FANCB cause Fanconi anemia complementation group B, an X-linked recessive disorder characterized by bone marrow failure, congenital abnormalities, and predisposition to acute myeloid leukemia and solid tumors.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Fanconi anemia complementation group B | Loss of FANCB function disrupts FA core complex assembly, preventing FANCD2/FANCI monoubiquitination and ICL repair, leading to genomic instability and bone marrow failure. | OMIM #300514; ClinVar; NCBI Gene |
| Acute myeloid leukemia (secondary) | FA pathway deficiency due to FANCB mutations increases susceptibility to leukemic transformation. | COSMIC; ClinVar |
| Squamous cell carcinoma (head and neck) | Impaired DNA repair in FA patients predisposes to epithelial cancers. | COSMIC; OMIM |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Bone marrow | 2.1 | Low |
| Testis | 4.3 | Medium |
| Spleen | 1.8 | Low |
| Thymus | 2.5 | Low |
| Lymph node | 1.9 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 3.2 | Embryonic kidney; moderate expression |
| K562 | 1.5 | Chronic myeloid leukemia; low expression |
| HeLa | 2.0 | Cervical carcinoma; low expression |
| HepG2 | 1.8 | Hepatocellular carcinoma; low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.482_483delAG | Frameshift | Unknown | Loss of function; truncation |
| c.839G>A (p.Trp280*) | Nonsense | Unknown | Premature stop; loss of function |
| c.1123C>T (p.Arg375*) | Nonsense | Unknown | Loss of function |
| c.1471C>T (p.Arg491*) | Nonsense | Unknown | Loss of function |
Mutation functional classification
Loss of Function (LOF)
Majority of reported FANCB mutations are loss-of-function (nonsense, frameshift, splice-site) leading to truncated or absent protein, resulting in FA core complex dysfunction.
Gain of Function (GOF)
No gain-of-function mutations reported for FANCB.
Dominant Negative (DN)
No dominant-negative mutations reported; FANCB is X-linked and hemizygous loss in males causes disease.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Fanconi anemia pathway (Reactome R-HSA-6783310)
• DNA interstrand crosslink repair (KEGG hsa03460)
• Homologous recombination (Reactome R-HSA-5693571)
Protein Summary
FANCB is a 95 kDa nuclear protein that forms a subcomplex with FAAP100 and FANCL, which is the E3 ubiquitin ligase module of the FA core complex. It is essential for the monoubiquitination of FANCD2 and FANCI. FANCB contains a putative nuclear localization signal and is required for the nuclear accumulation of the FA core complex. The protein is highly conserved in vertebrates and is expressed at low levels in most tissues, with highest expression in testis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FANCB Knockout HEK293 Cell Line | EDJ-KQ4577 | Human | 2187 | Details Get a Quote |
| FANCB Knockout A-549 Cell Line | EDJ-KQ27235 | Human | 2187 | Details Get a Quote |
| FANCB Knockout HCT 116 Cell Line | EDJ-KQ27236 | Human | 2187 | Details Get a Quote |
| FANCB Knockout HeLa Cell Line | EDJ-KQ27237 | Human | 2187 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records